Quantum BioPharma adds $1m in Bitcoin to treasury, eyes future crypto financing

Quantum BioPharma Ltd., a Nasdaq-listed biotechnology and medical research company, purchased $1 million worth of Bitcoin and other cryptocurrencies in a strategic move approved by its board of directors.

The company plans to allow future cryptocurrency funding and transactions, signaling confidence in the evolving cryptocurrency market.

The company revealed that cryptocurrency assets are held by a compliant custodian to ensure compliance with financial and auditing regulations. Its executives believe that this investment corresponds to the growing legitimacy of digital assets and the potential for shareholder returns.

Zeeshan Saeed, CEO of Quantum BioPharma, cited the progress made in the Bitcoin space (BTC) legal status and market acceptance as key factors behind the decision.

He also highlighted renewed optimism about crypto policies under President-elect Donald Trump and the introduction of Bitcoin-based cryptocurrencies. exchange traded funds by global asset managers.

“We are exploring innovative ways to grow our capital without it being used in operations,” Saeed said in a statement.

The company emphasized its commitment to monitoring market conditions and adjusting its cryptocurrency holdings as necessary. This marks Quantum BioPharma’s entry into a growing trend where traditional companies are diversifying their assets with Bitcoin and other digital currencies to capitalize on emerging financial trends.

Bitcoin reserves the new business standard?

The move is part of a broader institutional shift toward crypto adoption, as companies and asset managers increasingly integrate digital assets into their financial strategies.

Travala, a crypto-based travel booking platform, also recently introduced a Treasury reserve plan after exceeding $100 million in annual revenue. The plan is to hold reserves in Bitcoin and its native token to strengthen financial stability and growth.

Genius Group also expanded its Bitcoin treasury by acquiring194 Bitcoin for $18 million at an average price of $92,728 per Bitcoin. The move aligns with its “Bitcoin-first” strategy, which aims to allocate 90% of reserves to Bitcoin with a target of $120 million.